Henning Zelba
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- T-cell and B-cell Immunology
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 16
- Immunotherapy and Immune Responses 11
- Immune Cell Function and Interaction 5
- T-cell and B-cell Immunology 4
- Oncology 13
- Cancer Immunotherapy and Biomarkers 10
- CAR-T cell therapy research 5
- Cutaneous Melanoma Detection and Management 2
- Co-authors
- Graham Pawelec (14 shared papers)Claus Garbe (12 shared papers)Benjamin Weide (11 shared papers)Evelyna Derhovanessian (5 shared papers)Alexander Martens (7 shared papers)Thomas Eigentler (7 shared papers)Annette Pflugfelder (5 shared papers)Michele Maio (3 shared papers)
- Journals
- Vaccines (3 papers)Journal of Clinical Oncology (2 papers)Clinical Cancer Research (2 papers)OncoImmunology (2 papers)Cancer Immunology Immunotherapy (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Henning Zelba
23 papers receiving 891 citations
Peers
Comparison fields: 5 of 68
- Immunology 575
- Oncology 520
- Cancer Research 54
- Radiology, Nuclear Medicine and Imaging 52
- Molecular Biology 162
Countries citing papers authored by Henning Zelba
This map shows the geographic impact of Henning Zelba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henning Zelba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henning Zelba more than expected).
Fields of papers citing papers by Henning Zelba
This network shows the impact of papers produced by Henning Zelba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henning Zelba. The network helps show where Henning Zelba may publish in the future.
Co-authors
The 25 scholars most cited alongside Henning Zelba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 213 | |
| 2 | 2010 | 116 | |
| 3 | 2012 | 91 | |
| 4 | 2019 | 80 | |
| 5 | 2014 | 79 | |
| 6 | 2012 | 69 | |
| 7 | 2009 | 46 | |
| 8 | 2014 | 35 | |
| 9 | 2016 | 28 | |
| 10 | 2016 | 27 | |
| 11 | 2018 | 23 | |
| 12 | 2009 | 20 | |
| 13 | 2014 | 16 | |
| 14 | 2019 | 14 | |
| 15 | 2020 | 13 | |
| 16 | 2022 | 7 | |
| 17 | 2023 | 5 | |
| 18 | 2023 | 5 | |
| 19 | 2014 | 4 | |
| 20 | 2014 | 4 |
About Henning Zelba
Henning Zelba is a scholar working on Immunology, Oncology, Molecular Biology, Cancer Research and Infectious Diseases, having authored 24 papers that have together received 900 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (5 papers), T-cell and B-cell Immunology (4 papers), Cutaneous Melanoma Detection and Management (2 papers), vaccines and immunoinformatics approaches (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Immunology (575 citations), Oncology (520 citations), Cancer Research (54 citations), Radiology, Nuclear Medicine and Imaging (52 citations) and Molecular Biology (162 citations). Henning Zelba has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Graham Pawelec, Claus Garbe, Benjamin Weide, Evelyna Derhovanessian, Alexander Martens, Thomas Eigentler, Annette Pflugfelder, Michele Maio, Antje Sucker and Petra Büttner. Their work appears in journals such as Vaccines, Journal of Clinical Oncology, Clinical Cancer Research, OncoImmunology and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.